pre-ipo
Stage
About
Innovothera develops first-in-class synthetic small-molecule drugs using its proprietary AI platform DeepZema® to accelerate drug discovery targeting immune, inflammatory, fibrotic diseases, and cancer.
Explore Innovothera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.